The effect of a lutein based nutritional supplement on non-exudative age-related macular degeneration (AMD): a double-masked randomised controlled trial

ISRCTN ISRCTN78467674
DOI https://doi.org/10.1186/ISRCTN78467674
Secondary identifying numbers N/A
Submission date
20/06/2003
Registration date
11/09/2003
Last edited
11/01/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Study website

Contact information

Miss Hannah Bartlett
Scientific

Neuroscience Research Institute
School of Life and Health Sciences
Aston University
Aston Triangle
Birmingham
B4 7ET
United Kingdom

Email bartlehe@aston.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleThe effect of a lutein based nutritional supplement on non-exudative age-related macular degeneration (AMD): a double-masked randomised controlled trial
Study hypothesisAge-related macular degeneration is the leading cause of blind registration in the developed world. One aetiological hypothesis involves oxidation and the intrinsic vulnerability of the retina to damage via this process. This has prompted interest in the role of antioxidants in the prevention and treatment of this eye disease.
Ethics approval(s)Approved by the Aston University Human Sciences Ethical Committee.
ConditionAge-related macular degeneration
InterventionThe study formulation contains:
Lutein 10 mg
Vitamin C 250 mg
Vitamin E 34 mg
Vitamin A 750 µg
Zinc 10 mg
Copper 0.5 mg
Intervention typeSupplement
Primary outcome measure1. Distance and near Visual Acuity (VA) measured using Bailey-Lovie logMAR charts
2. Contrast sensitivity (CS) measured using a Pelli-Robson chart
3. Colour vision measured using the PV-16 quantitative colour vision test
4. Macular Mapping (MM) test
5. Eger Macular Stressometer (EMS) used to assess glare recovery
6. Fundus photographs of the macular will be assessed using colour and edge analysis software

Data collection will take place at baseline, nine, and 18 months.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/07/2003
Overall study end date01/01/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants159
Participant inclusion criteria1. Have to provide written informed consent
2. Have to be available for three visits to Aston University
3. Have to present with no ocular pathology in one eye, or no ocular pathology other than dry AMD in one eye. A cataract grading system consisting of grades one, two and three for each of cortical, nuclear, and posterior subcapsular cataracts has been developed. Participants presenting with lens opacities precluding fundus photography are excluded. Throughout the trial period, progression of any type of cataract to the successive grade will require the participant to withdraw.
Participant exclusion criteriaExclusion criteria include type I and II diabetes because vitamin E has been shown to affect glucose tolerance and diabetic retinopathy may confound the results. Those taking Warfarin medication are excluded as zinc may decrease its absorption and activity, as are those who use nutritional supplements that potentially raise vitamin and mineral intake above safe limits. The most recent guidelines for upper limits of nutritional supplementation are set out in the UK Food Standards Agency report. Neovascular AMD and other ocular disease that could potentially interfere with the results are excluded.
Recruitment start date01/07/2003
Recruitment end date01/01/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Neuroscience Research Institute
Birmingham
B4 7ET
United Kingdom

Sponsor information

Aston University (UK)
University/education

Neurosciences Research Institute
School of Life and Health Sciences
Aston Triangle
Birmingham
B4 7ET
England
United Kingdom

Website http://www.aston.ac.uk/
ROR logo "ROR" https://ror.org/05j0ve876

Funders

Funder type

University/education

College of Optometrists (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 10/10/2003 Yes No
Results article results 01/04/2008 Yes No

Editorial Notes

11/01/2018: publication reference added.